Today, our CFO, Matthew Norkunas, M.D., will present at the Canaccord Genuity 43rd Annual Growth Conference in Boston. Learn more here: https://bit.ly/3YtWzo1
Generation Bio’s Post
More Relevant Posts
-
Congratulations to Generation Bio Sr. Scientist Anthony Dawson for his presentation at the Cell & Gene Therapy International / BioProcess International Conference last week! Anthony discussed our Rapid Enzymatic Synthesis (RES) process, which is designed to significantly improve the speed, quality, and scalability of DNA manufacturing compared to traditional cell-based methods. If you missed it, you can check out the slides from Anthony's presentation on our website: https://lnkd.in/eDnPmsRK #BioProcessInternational #BPI2024 #CGT2024
-
We are pleased to announce the latest progress in our mission to unlock the full potential of genetic medicine through the latest advancements with our cell-targeted LNP (ctLNP) platform. Learn more in our press release here: https://lnkd.in/eiwzBrAz
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform - Generation Bio
investors.generationbio.com
-
Today, Generation Bio announced an exciting step forward in our mission to realize the full potential of non-viral DNA therapeutics with the development of a proprietary, novel DNA called immune-quiet DNA (iqDNA). Read our press release here to learn more: https://lnkd.in/eN8axuDw
-
-
Last week, our Chief Scientific Officer, Matthew Stanton, discussed the key hurdles for non-viral DNA delivery and innate immune stimulation, as well as strategies to address these challenges in an online webinar with the Oligonucleotide Therapeutics Society. Check it out here to learn more: https://bit.ly/45yQjxs
-
